Meakin_adjuvant_regimen_in_premenopausal_patients_with_breast_cancer._A_10-year_experience_using_ovarian_ablation_and_prednisolone_as_adjuvant_therapy_for_premenopausal_patients_with_breast_carcinoma,_emphasizing_tolerability_and_morbidity_is_reported._Thirty_patients_(15_aged_less_than_45_years,_15_aged_greater_than_or_equal_to_45_years;_range_28-54_years)_underwent_mastectomy/lumpectomy_with_axillary_clearance_(with_or_without_local_irradiation)_followed_by_ovarian_irradiation_and_prednisolone_therapy_(2.5_mg_three_times_daily_for_5_years)._Patients_were_reviewed_every_3_months_for_the_first_3_years_and_every_6_months_thereafter._Follow-up_was_between_1.5_and_10_years_(median_5_years)._Twenty-four_patients_are_still_alive._Three_patients_stopped_therapy_because_of_side-effects._There_was_a_mean(s.e.m.)_weight_gain_of_8.46(1.69)_per_cent_on_therapy._Nineteen_patients_have_been_weaned_off_prednisolone_over_a_period_of_0.5-7.5_months_(median_2_months)_and_the_median_length_of_time_off_steroids_is_now_3_years_(range_0.5-5_years)._This_regimen_appears_to_be_associated_with_an_acceptable_level_of_patient_tolerability_and_a_low_chronic_morbidity_rate_and_should_be_considered_as_an_alternative_to_adjuvant_systemic_cytotoxic_therapy.